261 related articles for article (PubMed ID: 21459797)
1. Urinary glycoprotein biomarker discovery for bladder cancer detection using LC/MS-MS and label-free quantification.
Yang N; Feng S; Shedden K; Xie X; Liu Y; Rosser CJ; Lubman DM; Goodison S
Clin Cancer Res; 2011 May; 17(10):3349-59. PubMed ID: 21459797
[TBL] [Abstract][Full Text] [Related]
2. Bladder cancer associated glycoprotein signatures revealed by urinary proteomic profiling.
Kreunin P; Zhao J; Rosser C; Urquidi V; Lubman DM; Goodison S
J Proteome Res; 2007 Jul; 6(7):2631-9. PubMed ID: 17518487
[TBL] [Abstract][Full Text] [Related]
3. Proteomic analysis of urinary biomarker candidates for nonmuscle invasive bladder cancer.
Lindén M; Lind SB; Mayrhofer C; Segersten U; Wester K; Lyutvinskiy Y; Zubarev R; Malmström PU; Pettersson U
Proteomics; 2012 Jan; 12(1):135-44. PubMed ID: 22065568
[TBL] [Abstract][Full Text] [Related]
4. Development of a universal metabolome-standard method for long-term LC-MS metabolome profiling and its application for bladder cancer urine-metabolite-biomarker discovery.
Peng J; Chen YT; Chen CL; Li L
Anal Chem; 2014 Jul; 86(13):6540-7. PubMed ID: 24877652
[TBL] [Abstract][Full Text] [Related]
5. A multi-analyte assay for the non-invasive detection of bladder cancer.
Goodison S; Chang M; Dai Y; Urquidi V; Rosser CJ
PLoS One; 2012; 7(10):e47469. PubMed ID: 23094052
[TBL] [Abstract][Full Text] [Related]
6. Multiplex protein signature for the detection of bladder cancer in voided urine samples.
Rosser CJ; Ross S; Chang M; Dai Y; Mengual L; Zhang G; Kim J; Urquidi V; Alcaraz A; Goodison S
J Urol; 2013 Dec; 190(6):2257-62. PubMed ID: 23764080
[TBL] [Abstract][Full Text] [Related]
7. Comparative Tissue Proteomics of Microdissected Specimens Reveals Novel Candidate Biomarkers of Bladder Cancer.
Chen CL; Chung T; Wu CC; Ng KF; Yu JS; Tsai CH; Chang YS; Liang Y; Tsui KH; Chen YT
Mol Cell Proteomics; 2015 Sep; 14(9):2466-78. PubMed ID: 26081836
[TBL] [Abstract][Full Text] [Related]
8. Detection of bladder cancer using a point-of-care proteomic assay.
Grossman HB; Messing E; Soloway M; Tomera K; Katz G; Berger Y; Shen Y
JAMA; 2005 Feb; 293(7):810-6. PubMed ID: 15713770
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic potential of urinary α1-antitrypsin and apolipoprotein E in the detection of bladder cancer.
Urquidi V; Goodison S; Ross S; Chang M; Dai Y; Rosser CJ
J Urol; 2012 Dec; 188(6):2377-83. PubMed ID: 23088986
[TBL] [Abstract][Full Text] [Related]
10. Investigation of CCL18 and A1AT as potential urinary biomarkers for bladder cancer detection.
Miyake M; Ross S; Lawton A; Chang M; Dai Y; Mengual L; Alcaraz A; Giacoia EG; Goodison S; Rosser CJ
BMC Urol; 2013 Sep; 13():42. PubMed ID: 24011266
[TBL] [Abstract][Full Text] [Related]
11. Proteomic Analysis of Urine to Identify Breast Cancer Biomarker Candidates Using a Label-Free LC-MS/MS Approach.
Beretov J; Wasinger VC; Millar EK; Schwartz P; Graham PH; Li Y
PLoS One; 2015; 10(11):e0141876. PubMed ID: 26544852
[TBL] [Abstract][Full Text] [Related]
12. Comparison of telomerase activity and matrix metalloproteinase-9 in voided urine and bladder wash samples as a useful diagnostic tool for bladder cancer.
Eissa S; Labib RA; Mourad MS; Kamel K; El-Ahmady O
Eur Urol; 2003 Dec; 44(6):687-94. PubMed ID: 14644121
[TBL] [Abstract][Full Text] [Related]
13. Enrichment and identification of glycoproteins in human saliva using lectin magnetic bead arrays.
Caragata M; Shah AK; Schulz BL; Hill MM; Punyadeera C
Anal Biochem; 2016 Mar; 497():76-82. PubMed ID: 26743719
[TBL] [Abstract][Full Text] [Related]
14. Targeting amine- and phenol-containing metabolites in urine by dansylation isotope labeling and liquid chromatography mass spectrometry for evaluation of bladder cancer biomarkers.
Chen YT; Huang HC; Hsieh YJ; Fu SH; Li L; Chen CL; Chu LJ; Yu JS
J Food Drug Anal; 2019 Apr; 27(2):460-474. PubMed ID: 30987717
[TBL] [Abstract][Full Text] [Related]
15. Vascular endothelial growth factor, carbonic anhydrase 9, and angiogenin as urinary biomarkers for bladder cancer detection.
Urquidi V; Goodison S; Kim J; Chang M; Dai Y; Rosser CJ
Urology; 2012 May; 79(5):1185.e1-6. PubMed ID: 22386755
[TBL] [Abstract][Full Text] [Related]
16. A Comprehensive Investigation toward the Indicative Proteins of Bladder Cancer in Urine: From Surveying Cell Secretomes to Verifying Urine Proteins.
Guo J; Ren Y; Hou G; Wen B; Xian F; Chen Z; Cui P; Xie Y; Zi J; Lin L; Wu S; Li Z; Wu L; Lou X; Liu S
J Proteome Res; 2016 Jul; 15(7):2164-77. PubMed ID: 27265680
[TBL] [Abstract][Full Text] [Related]
17. Comparative and targeted proteomic analyses of urinary microparticles from bladder cancer and hernia patients.
Chen CL; Lai YF; Tang P; Chien KY; Yu JS; Tsai CH; Chen HW; Wu CC; Chung T; Hsu CW; Chen CD; Chang YS; Chang PL; Chen YT
J Proteome Res; 2012 Dec; 11(12):5611-29. PubMed ID: 23082778
[TBL] [Abstract][Full Text] [Related]
18. Urinary metabolomics for discovering metabolic biomarkers of bladder cancer by UPLC-MS.
Wang R; Kang H; Zhang X; Nie Q; Wang H; Wang C; Zhou S
BMC Cancer; 2022 Feb; 22(1):214. PubMed ID: 35220945
[TBL] [Abstract][Full Text] [Related]
19. Performance of the Bladder EpiCheck™ Methylation Test for Patients Under Surveillance for Non-muscle-invasive Bladder Cancer: Results of a Multicenter, Prospective, Blinded Clinical Trial.
Witjes JA; Morote J; Cornel EB; Gakis G; van Valenberg FJP; Lozano F; Sternberg IA; Willemsen E; Hegemann ML; Paitan Y; Leibovitch I
Eur Urol Oncol; 2018 Sep; 1(4):307-313. PubMed ID: 31100252
[TBL] [Abstract][Full Text] [Related]
20. The value of combined use of survivin mRNA and matrix metalloproteinase 2 and 9 for bladder cancer detection in voided urine.
Eissa S; Badr S; Elhamid SA; Helmy AS; Nour M; Esmat M
Dis Markers; 2013; 34(1):57-62. PubMed ID: 22960341
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
